- Home
- AIMD vs CPHI Comparison
AIMD vs CPHI Comparison
Compare AIMD & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIMD
- CPHI
- Stock Information
- Founded
- AIMD 1984
- CPHI N/A
- Country
- AIMD United States
- CPHI China
- Employees
- AIMD N/A
- CPHI N/A
- Industry
- AIMD Biotechnology: Pharmaceutical Preparations
- CPHI Biotechnology: Pharmaceutical Preparations
- Sector
- AIMD Health Care
- CPHI Health Care
- Exchange
- AIMD Nasdaq
- CPHI Nasdaq
- Market Cap
- AIMD 8.2M
- CPHI 7.3M
- IPO Year
- AIMD N/A
- CPHI N/A
- Fundamental
- Price
- AIMD $2.70
- CPHI $1.81
- Analyst Decision
- AIMD
- CPHI
- Analyst Count
- AIMD 0
- CPHI 0
- Target Price
- AIMD N/A
- CPHI N/A
- AVG Volume (30 Days)
- AIMD 63.9K
- CPHI 148.4K
- Earning Date
- AIMD 08-04-2025
- CPHI 08-13-2025
- Dividend Yield
- AIMD N/A
- CPHI N/A
- EPS Growth
- AIMD N/A
- CPHI N/A
- EPS
- AIMD N/A
- CPHI N/A
- Revenue
- AIMD $106,207.00
- CPHI $4,295,377.00
- Revenue This Year
- AIMD N/A
- CPHI N/A
- Revenue Next Year
- AIMD N/A
- CPHI N/A
- P/E Ratio
- AIMD N/A
- CPHI N/A
- Revenue Growth
- AIMD 13.38
- CPHI N/A
- 52 Week Low
- AIMD $2.00
- CPHI $1.20
- 52 Week High
- AIMD $5.35
- CPHI $3.35
- Technical
- Relative Strength Index (RSI)
- AIMD 50.23
- CPHI 51.39
- Support Level
- AIMD $2.32
- CPHI $1.55
- Resistance Level
- AIMD $2.94
- CPHI $1.91
- Average True Range (ATR)
- AIMD 0.23
- CPHI 0.18
- MACD
- AIMD -0.00
- CPHI 0.03
- Stochastic Oscillator
- AIMD 68.75
- CPHI 58.62
About AIMD Ainos Inc.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.
About CPHI China Pharma Holdings Inc.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.